Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Conference Highlights ASH
Siltuximab: Monoclonal Antibody Relieves Symptoms of Castleman’s Disease
Read More
Conference Highlights ASH
More Transplants Made Possible Through Haploidentical Donors
Read More
Conference Highlights ASH
Hospital Readmission After Stem-Cell Transplant Decreases Survival
Read More
Conference Highlights ASH
JAK1/2 Inhibitor Ruxolitinib Improves Survival in High-Risk Myelofibrosis
Read More
Perspectives
Increasing Emphasis on Costs in the Management of Patients with Hematologic Cancers
Read More
Lymphoma
Rituximab Maintenance Extends Remission in Follicular Lymphoma, but Overall Survival Unaffected
Read More
Lymphoma
Surveillance Scanning in Transformed Indolent Lymphoma of Limited Clinical Benefit
Read More
Lymphoma
PI3K Inhibitors Main Focus of Drug Pipeline for Lymphoma
Read More
Promise of Genomic Sequencing for Clinical Decision-Making in Hematopoietic Cancers
Read More
Multiple Myeloma
,
Oncology
Myeloma Drug Arsenal Expanding to New Classes
Read More
155
156
157
158
159
160
161
Page 158 of 244
Results 1571 - 1580 of 2439
